Catherine Novack
Stock Analyst at Jones Trading
(0.66)
# 4,031
Out of 5,005 analysts
21
Total ratings
27.78%
Success rate
-10.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $16.08 | +105.22% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $13.06 | +129.71% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $7.36 | +294.02% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.63 | +852.23% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.56 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $65.78 | -31.59% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.45 | +348.98% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $46.22 | +181.26% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.33 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $7.15 | +123.78% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.87 | +187.47% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.18 | +496.33% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.10 | +9.89% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.20 | +587.50% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.92 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.59 | +26,845.10% | 1 | Jul 21, 2023 |
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $16.08
Upside: +105.22%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $13.06
Upside: +129.71%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $7.36
Upside: +294.02%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.63
Upside: +852.23%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.56
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $65.78
Upside: -31.59%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.45
Upside: +348.98%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $46.22
Upside: +181.26%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.33
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.15
Upside: +123.78%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.87
Upside: +187.47%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.18
Upside: +496.33%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $9.10
Upside: +9.89%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.20
Upside: +587.50%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.92
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.59
Upside: +26,845.10%